Company Filing History:
Years Active: 1998
Title: The Remarkable Contributions of Ursula Garrigues
Introduction
Ursula Garrigues, an accomplished inventor based in Bainbridge Island, Washington, has made significant strides in the field of biotechnology. With a passion for scientific innovation, she has secured a patent that showcases her expertise and dedication to advancing medical research.
Latest Patents
Garrigues holds a patent for the monoclonal antibody BR110 and its associated uses. This groundbreaking invention provides internalizing ligands, known as BR110 ligands, which specifically recognize and bind to the BR110 antigen. Once the ligand binds to the antigen, they form a complex that can be detected using well-established methods and commercial systems. This advancement not only enhances detection capabilities but also has the potential to lead to novel applications in therapeutic and diagnostic areas.
Career Highlights
Ursula Garrigues is associated with Bristol-Myers Squibb Company, a global leader in biopharmaceutical innovation. Her work at this esteemed organization allows her to contribute to the development of cutting-edge therapies that have the potential to improve patients' lives. With a keen focus on innovative research, she continues to push the boundaries of what is possible in the medical field.
Collaborations
Throughout her career, Garrigues has collaborated with several notable professionals, including Karl E. Hellstrom and Ingegerd E. Hellstrom. These partnerships reflect her commitment to teamwork and collaboration in the scientific community, showcasing the importance of collective efforts in achieving groundbreaking results.
Conclusion
Ursula Garrigues exemplifies the spirit of innovation and dedication that drives advancements in biotechnology. Her patent for the BR110 monoclonal antibody not only highlights her inventiveness but also underscores the potential impact of her work in the medical field. As she continues her journey in biotechnology, her contributions will undoubtedly lead to transformative changes in healthcare and diagnostics.